Deputy Director of the Oncology Administrative Office; Member of the Youth Committee of the Chinese Anti-Cancer Association Lung Cancer Professional Committee; Standing Committee Member of the Shanghai Lung Cancer Targeted Immunotherapy Committee; Member of the Chinese Society of Clinical Oncology (CSCO) of the Chinese Anti-Cancer Association; Member of the American Society of Clinical Oncology (ASCO). Editorial Board Member of the *Chinese Journal of Lung Cancer*. With nearly 20 years of clinical experience, he has extensive expertise in the diagnosis and treatment of lung cancer. He specializes in the diagnosis and differential diagnosis of lung cancer, with a particular focus on individualized precision treatment for non-small cell lung cancer (including chemotherapy and targeted therapy). His research interests include basic and clinical studies on lung cancer (investigation of resistance pathways in targeted therapy for non-small cell lung cancer, peripheral blood liquid biopsy for lung cancer, and nano-active targeted chemotherapy for non-small cell lung cancer). In 2013, he received the Second Prize of the Chinese Medical Science and Technology Award and the First Prize of the Shanghai Medical Science and Technology Award. He has led two projects funded by the National Natural Science Foundation of China, one project funded by the Shanghai Municipal Science and Technology Commission Natural Science Foundation, and one sub-project of a key project in the Shanghai Zhangjiang Industrial Park. He has published 40 papers in core domestic and international journals, including 20 SCI-indexed papers. He is the editor-in-chief of one monograph, *Diagnostic and Treatment Strategies and Analysis of Difficult Pulmonary Cases*, and a co-author of two additional monographs.